Search Results - "TAPONECO, F"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Activin A and inhibin B in extra-embryonic coelomic and amniotic fluids, and maternal serum in early pregnancy by Luisi, S., Battaglia, C., Florio, P., D'Ambrogio, G., Taponeco, F., Santuz, M., Genazzani, A.R., Petraglia, F.

    Published in Placenta (Eastbourne) (01-07-1998)
    “…Activin A and inhibin B levels were measured, using a two-site enzyme immunoassay, in extra-embryonic coelomic fluid, amniotic fluid and maternal serum samples…”
    Get full text
    Journal Article
  2. 2

    Expression and prognostic significance of urokinase and plasminogen activator inhibitor type-1 in endometrial hyperplasia and cancer by Taponeco, F, Curcio, C, Giuntini, A, Nardini, V, Fornaciari, G, Artini, P G, D'Ambrogio, G, Genazzani, A R

    “…Proteolytic enzymes, like urokinase (uPA) and plasminogen activator inhibitor type-1 (PAI-1), are involved in remodelling tissues during invasion and…”
    Get more information
    Journal Article
  3. 3

    Hormone replacement therapy in perimenopausal women with a low dose oral contraceptive preparation: effects on bone mineral density and metabolism by Gambacciani, M, Spinetti, A, Cappagli, B, Taponeco, F, Maffei, S, Piaggesi, L, Fruzzetti, F, Fioretti, P

    Published in Maturitas (01-08-1994)
    “…In a 2-year longitudinal, calcium-controlled study we evaluated bone density and metabolism in perimenopausal women with initial ovarian failure, and the…”
    Get more information
    Journal Article
  4. 4

    Effects of ipriflavone administration on bone mass and metabolism in ovariectomized women by GAMBACCIANI, M, SPINETTI, A, CAPPAGLI, B, TAPONECO, F, FELIPETTO, R, PARRINI, D, CAPPELLI, N, FIORETTI, P

    Published in Journal of endocrinological investigation (01-05-1993)
    “…The aim of the present study was to assess the effects of ipriflavone administration in the prevention of the rapid bone loss that follows ovariectomy in…”
    Get full text
    Journal Article
  5. 5

    Treatment of postmenopausal vertebral osteopenia with monofluorophospate: a long-term calcium-controlled study by Gambacciani, M, Spinetti, A, Taponeco, F, Piaggesi, L, Cappagli, B, Ciaponi, M, Rovati, L C, Genazzani, A R

    Published in Osteoporosis international (01-11-1995)
    “…The aim of the present study was to assess the effects of the new fluorine pro-drug monofluorophosphate (MFP) in postmenopausal women with vertebral osteopenia…”
    Get full text
    Journal Article
  6. 6

    Effects of continuous and cyclic nasal calcitonin administration in ovariectomized women by Fioretti, P, Gambacciani, M, Taponeco, F, Melis, G B, Capelli, N, Spinetti, A

    Published in Maturitas (01-12-1992)
    “…The aim of the present study was to assess the effects of continuous and cyclic salmon calcitonin (sCT) administration in the prevention of the rapid bone loss…”
    Get more information
    Journal Article
  7. 7

    Prospective evaluation of calcium and estrogen administration on bone mass and metabolism after ovariectomy by Gambacciani, M, Spinetti, A, Taponeco, F, Ciaponi, M, Cima, G P, Teti, G C, Genazzani, A R

    Published in Gynecological endocrinology (1995)
    “…We evaluated the effects of low-dose ethinylestradiol administration in the prevention of the rapid bone loss that follows ovariectomy in women. After 10-30…”
    Get more information
    Journal Article
  8. 8

    Longitudinal evaluation of perimenopausal vertebral bone loss: effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism by Gambacciani, M, Spinetti, A, Taponeco, F, Cappagli, B, Piaggesi, L, Fioretti, P

    Published in Obstetrics and gynecology (New York. 1953) (01-03-1994)
    “…To characterize the pattern of biochemical markers of bone metabolism and vertebral bone mineral density in eumenorrheic and oligomenorrheic perimenopausal…”
    Get more information
    Journal Article
  9. 9
  10. 10

    The relative contributions of menopause and aging to postmenopausal vertebral osteopenia by Gambacciani, M, Spinetti, A, de Simone, L, Cappagli, B, Maffei, S, Taponeco, F, Fioretti, P

    “…Lumbar spine bone mineral density (BMD) was measured by dual energy x-ray absorptiometry in 2190 normal postmenopausal women (PMW). BMD was loosely correlated…”
    Get more information
    Journal Article
  11. 11

    Indication of hysteroscopy in tamoxifen treated breast cancer patients by Taponeco, F, Curcio, C, Fasciani, A, Giuntini, A, Artini, P G, Fornaciari, G, Petraglia, F, Genazzani, A R

    “…The aim of this study was to indicate the patients treated with tamoxifen for breast cancer in which hysteroscopy with biopsy should be considered mandatory…”
    Get more information
    Journal Article
  12. 12

    Bone loss in perimenopausal women: a longitudinal study by Gambacciani, M, Spinetti, A, Taponeco, F, Cappagli, B, Maffei, S, Manetti, P, Piaggesi, L, Fioretti, P

    Published in Maturitas (01-03-1994)
    “…A longitudinal evaluation of bone mineral density (BMD) and metabolism was performed in premenopausal women. During the 2-year observation period, the…”
    Get more information
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Ipriflavone prevents the bone mass reduction in premenopausal women treated with gonadotropin hormone-releasing hormone agonists by Gambacciani, M, Spinetti, A, Piaggesi, L, Cappagli, B, Taponeco, F, Manetti, P, Weiss, C, Teti, G C, La Commare, P, Facchini, V

    Published in Bone and mineral (01-07-1994)
    “…In the present study we assessed the effects of ipriflavone in the prevention of increased bone turnover and the rapid bone loss that follows medical induced…”
    Get more information
    Journal Article